As of 2025-02-16, the Relative Valuation of Utah Medical Products Inc (UTMD) is 163.94 USD. This relative valuation is based on P/E multiples. With the latest stock price at 61.05 USD, the upside of Utah Medical Products Inc based on Relative Valuation is 168.5%.
The range of the Relative Valuation is 123.18 - 205.15 USD.
Range | Selected | |
Trailing P/E multiples | 38.9x - 45.6x | 44.8x |
Forward P/E multiples | 31.3x - 34.6x | 32.1x |
Fair Price | 123.18 - 205.15 | 163.94 |
Upside | 101.8% - 236.0% | 168.5% |
Date | P/E |
2025-02-14 | 13.56 |
2025-02-13 | 13.72 |
2025-02-12 | 13.45 |
2025-02-11 | 13.56 |
2025-02-10 | 13.43 |
2025-02-07 | 13.30 |
2025-02-06 | 13.31 |
2025-02-05 | 13.33 |
2025-02-04 | 13.33 |
2025-02-03 | 13.31 |
2025-01-31 | 13.60 |
2025-01-30 | 13.60 |
2025-01-29 | 13.62 |
2025-01-28 | 14.00 |
2025-01-27 | 14.26 |
2025-01-24 | 13.98 |
2025-01-23 | 13.94 |
2025-01-22 | 13.96 |
2025-01-21 | 13.95 |
2025-01-17 | 13.81 |
2025-01-16 | 13.77 |
2025-01-15 | 13.97 |
2025-01-14 | 13.66 |
2025-01-13 | 13.56 |
2025-01-10 | 13.53 |
2025-01-08 | 13.54 |
2025-01-07 | 13.48 |
2025-01-06 | 13.53 |
2025-01-03 | 13.63 |
2025-01-02 | 13.63 |
2024-12-31 | 13.66 |
2024-12-30 | 13.53 |
2024-12-27 | 13.75 |
2024-12-26 | 13.68 |
2024-12-24 | 13.65 |
2024-12-23 | 13.58 |
2024-12-20 | 13.56 |
2024-12-19 | 13.79 |
2024-12-18 | 13.78 |
2024-12-17 | 13.89 |
2024-12-16 | 13.99 |
2024-12-13 | 13.98 |
2024-12-12 | 14.14 |
2024-12-11 | 14.21 |
2024-12-10 | 14.15 |
2024-12-09 | 14.13 |
2024-12-06 | 14.18 |
2024-12-05 | 14.16 |
2024-12-04 | 14.28 |
2024-12-03 | 14.31 |